Therapeutic Guidelines Limited was recently selected by the Department of Health and Aged Care as the new publisher of Australian Prescriber. All volumes of the journal including new issues can be ...

This leaflet provides important information about RejuveNail Antifungal Nail Lacquer. Please read it carefully before you start using it. It does not contain all of the available information. It does ...

This leaflet answers some common questions about PREDNEFRIN® FORTE eye drops, (including how to use the eye drops). It does not contain all the available information. It does not take the place of ...

Therapeutic Guidelines Limited was recently selected by the Department of Health and Aged Care as the new publisher of Australian Prescriber. All volumes of the journal including new issues can be ...

This leaflet answers some common questions about Ozmep. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have ...

Therapeutic Guidelines Limited was recently selected by the Department of Health and Aged Care as the new publisher of Australian Prescriber. All volumes of the journal including new issues can be ...

Therapeutic Guidelines Limited was recently selected by the Department of Health and Aged Care as the new publisher of Australian Prescriber. All volumes of the journal including new issues can be ...

1. Why am I using Gliclazide Lupin MR? Gliclazide Lupin MR contains the active ingredient gliclazide. Gliclazide Lupin MR is used to control blood glucose (sugar) in patients with type II diabetes ...

Therapeutic Guidelines Limited was recently selected by the Department of Health and Aged Care as the new publisher of Australian Prescriber. All volumes of the journal including new issues can be ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. KEFLEX contains the active ingredient cefalexin monohydrate. KEFLEX is ...

This website is currently under review by the Australian Commission on Safety and Quality in Health Care as part of the redesign of the Quality Use of Diagnostics, Therapeutics and Pathology program.

if there is anything you do not understand in this leaflet, if you are worried about taking your medicine, or to obtain the most up-to-date information. You can also ...